Edition:
India

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

1.38USD
1:30am IST
Change (% chg)

$-0.05 (-3.50%)
Prev Close
$1.43
Open
$1.42
Day's High
$1.42
Day's Low
$1.38
Volume
11,706
Avg. Vol
45,036
52-wk High
$4.25
52-wk Low
$0.63

Chart for

About

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of therapeutics. The Company focuses on discovering, developing and commercializing regenerative medicine and large molecule products for the treatment of disease, with a primary focus on the... (more)

Overall

Beta: -2.65
Market Cap(Mil.): $67.20
Shares Outstanding(Mil.): 23.50
Dividend: --
Yield (%): --

Financials

BRIEF-Capricor Q4 Earnings Per Share $0.42

* CAPRICOR PRESENTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND CORPORATE UPDATE

15 Mar 2018

BRIEF-Capricor Therapeutics Says ‍FDA Has Granted CAP-1002 RMAT Designation

* CAPRICOR THERAPEUTICS SAYS ‍FDA HAS GRANTED CAP-1002 REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION - SEC FILING Source text : (http://bit.ly/2s6RQ09) Further company coverage:

05 Feb 2018

BRIEF-Capricor Therapeutics Appoints Anthony Bergmann As CFO, Eff Jan 1, 2018 - SEC Filing

* CAPRICOR THERAPEUTICS INC SAYS HAS APPOINTED ANTHONY BERGMANN AS CHIEF FINANCIAL OFFICER, EFFECTIVE JANUARY 1, 2018 - SEC FILING

23 Dec 2017

Earnings vs. Estimates